Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 30, 2025Advanced Healthcare Materials

Recent Advances in Embolic Agents for Transarterial Chemoembolization of Hepatocellular Carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYiming LiuJLJiacheng LiuCZChuansheng Zheng

Discussion

Loading...

Member takes

Overview

Review highlights advances in embolic agents for transarterial chemoembolization, suggesting improved efficacy through physicochemical properties.

Key Points

  • Transarterial chemoembolization improved localized chemotherapy in hepatocellular carcinoma, indicating enhanced treatment options.
  • Recent advancements in embolic agents include innovations in drug-loading capacity and increased radiopacity compared to traditional options.
  • Systematic review of embolic agent evolution focuses on smart hydrogels and their responsiveness to microenvironmental stimuli.
  • Future directions for advanced embolic systems emphasize the need for clinical translation and precision embolotherapy.

Cite This Study

Liu et al. (2025) studied this question.

synapsesocial.com/papers/692b9da91d383f2b2a37a56dhttps://doi.org/10.1002/adhm.202502566
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Integrating Combination Therapy and Smart Embolic Materials to Overcome the Therapeutic Ceiling of Transarterial Chemoembolization in Hepatocellular Carcinoma2026
  2. 2Advanced Microsphere and Hydrogel Platforms for Precision Interventional Therapy of Hepatocellular Carcinoma2025
  3. 3Advanced Microsphere and Hydrogel Platforms for Precision Interventional Therapy of Hepatocellular Carcinoma2025
  4. 4Application of Nanotechnology in TACE Treatment of Liver Cancer2025
  5. 5Evolution of embolization microspheres from physical occlusion to theranostic modulation in hepatocellular carcinoma treatment2026